Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 12,051 | 11,457 | 20,257 | 12,134 | 15,137 |
| Operating Income | -12,051 | -11,457 | -20,257 | -12,134 | -15,137 |
| Interest Expense | 0 | 0 | 0 | 0 | 281 |
| Other Income | 201 | 336 | -7,167 | 175 | 3 |
| Pre-tax Income | -11,850 | -11,122 | -27,424 | -11,958 | -15,415 |
| Income Tax | N/A | N/A | N/A | -531 | -1,001 |
| Net Income Continuous | -11,850 | -11,122 | -27,424 | -11,428 | -14,414 |
| Net Income | $-11,850 | $-11,122 | $-27,424 | $-11,428 | $-14,414 |
| EPS Basic Total Ops | -3.87 | -8.48 | -34.05 | -15.00 | -50.80 |
| EPS Basic Continuous Ops | -3.87 | -8.48 | -34.05 | -14.92 | -38.44 |
| EPS Diluted Total Ops | -3.87 | -8.48 | -34.05 | -15.00 | -50.80 |
| EPS Diluted Continuous Ops | -3.87 | -8.48 | -34.05 | -14.92 | -38.44 |
| EPS Diluted Before Non-Recurring Items | -3.87 | -8.48 | -25.00 | -15.00 | -27.60 |
| EBITDA(a) | $-12,050 | $-11,457 | $-19,353 | $-11,343 | $-14,333 |